Connect with us

Hi, what are you looking for?

Economy

COVID-19 reinfection rare, but more common in older people

LONDON — The majority of people who have had coronavirus disease 2019 (COVID-19) are protected from getting it again for at least six months, a study published on Wednesday showed, but older people are more prone to reinfection than younger people.

The study, appearing in the Lancet medical journal, found that just 0.65% of patients tested positive a second time for COVID-19 after previously being infected during Denmark’s first and second waves. That was much lower than the 3.27% who were positive for the virus using highly accurate PCR tests after initially being negative.

However, the study found that people over the age of 65 had only 47% protection against repeat infection, compared to 80% protection for younger people.

“Our study confirms what a number of others appeared to suggest: reinfection with COVID-19 is rare in younger, healthy people, but the elderly are at greater risk of catching it again,” said Steen Ethelberg of Denmark’s Statens Serum Institut.

“Since older people are also more likely to experience severe disease symptoms, and sadly die, our findings make clear how important it is to implement policies to protect the elderly during the pandemic.”

The authors of the study found no evidence that protection against reinfection declined over a six month follow-up period, but said further studies were needed to assess protection against reinfection from variants of the coronavirus.

The data analyzed was collected through Denmark’s national testing strategy, under which 69% of the population, or 4 million people, were tested over the course of 2020.

Commenting on the results, Imperial College London professors Rosemary Boyton and Danny Altmann, said the results showed lower protection and were “more concerning” than previous studies.

“These data are all confirmation, if it were needed, that for SARS-CoV-2 the hope of protective immunity through natural infections might not be within our reach and a global vaccination programme with high efficacy vaccines is the enduring solution,” they said in a linked comment piece also published in the Lancet. — Reuters

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest

Investing

Lowering VAT charges on fuel may be politically attractive but is not good news for those who will struggle the most, say leading tax...

Investing

An estimated 3 per cent of the workforce was signed off in late December and a fifth of businesses reported increased cancellations amid the...

Investing

Mark Zuckerberg could be forced to pay most British Facebook users about £50 each if a landmark legal action alleging that the site abused...

Investing

France has reopened its borders to British tourists after ministers in Paris eased restrictions on non-essential travel. From this morning, Britons travelling to the...

Investing

People struck down with the Omicron variant of the coronavirus are buying so much paracetamol that supplies are running low in many shops. Official...

Investing

Covid Passports are to be abandoned within days after Sajid Javid effectively killed off the policy. The health secretary has concluded that Covid-19 certification...

You May Also Like

Investing

Having a good Instagram marketing agency to back up your Instagram account is an absolute must going into the new year. With competition stronger...

Economy

Ivermectin, an existing drug against parasites including head lice, has had a checkered history when it comes to treating COVID-19. The bulk of studies...

Investing

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered throughout...

Investing

As a traditionally rigid insurance industry becomes bogged down by antiquated processes and operations, a handful of industry leaders are seeking to shake things...

Disclaimer: SmartRetirementReport.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2021 SmartRetirementReport. All Rights Reserved.